All Stories

  1. Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice

    Article • Life Sciences, October 2020, Elsevier

    Dr Yulia A Desheva

  2. Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines

    Article • Antibodies, May 2020, MDPI AG

    Dr Yulia A Desheva

  3. The prevalence of conjunctivitis in patients with novel coronavirus (COVID-19) and preventive measures

    Article • Russian Journal of Clinical Ophthalmology, January 2020, LLC Russian Medical Journal

    Dr Yulia A Desheva

  4. Contribution of antibody-dependent enhancement to the pathogenesis of coronavirus infections

    Article • AIMS Allergy and Immunology, January 2020, American Institute of Mathematical Sciences (AIMS)

    Dr Yulia A Desheva

  5. Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice

    Article • PLoS ONE, September 2019, PLOS

    Dr Yulia A Desheva, GALINA LEONTEVA

  6. INDUCTION OF CROSS-REACTIVE ANTIBODIES IN MICE IMMUNIZED WITH CONSERVED LINEAR B-CELL EPITOPES DERIVED FROM INFLUENZA A VIRUS NEURAMINIDASE

    Article • Russian Journal of Infection and Immunity, June 2019, SPb RAACI

    Dr Yulia A Desheva

  7. Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections

    Article • PLoS ONE, June 2019, PLOS

    Dr Yulia A Desheva

  8. Introductory Chapter: Human Adenoviruses

    Article • March 2019, IntechOpen

    Dr Yulia A Desheva

  9. Adenoviruses

    Article • March 2019, IntechOpen

    Dr Yulia A Desheva

  10. Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection

    Article • Heliyon, February 2019, Elsevier

    Dr Yulia A Desheva

  11. Preparing Live Influenza Vaccines against Potential Pandemic Influenza Using Nonpathogenic Avian Influenza Viruses and Cold-Adapted Master Donor Strain

    Article • September 2018, IntechOpen

    Dr Yulia A Desheva

  12. Anti–Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model

    Article • Probiotics and Antimicrobial Proteins, August 2018, Springer Science + Business Media

    Dr Yulia A Desheva

  13. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals

    Article • PLoS ONE, May 2018, PLOS

    Dr Yulia A Desheva

  14. Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides

    Article • Virology Research and Treatment, January 2017, SAGE Publications

    Dr Yulia A Desheva, Prof. Alexander N Suvorov

  15. Baculovirus as a platform for the anchorage of hemagglutinin from influenza virus

    Article • Journal of Immunological Techniques in Infectious Diseases, January 2017, OMICS Publishing Group

    Dr Yulia A Desheva

  16. The crystal structure of an orthomyxovirus matrix protein reveals mechanisms for self-polymerization and membrane association

    Article • Journal of Immunological Techniques in Infectious Diseases, January 2017, OMICS Publishing Group

    Dr Yulia A Desheva

  17. Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides

    Article • The Open Microbiology Journal, October 2016, Bentham Science Publishers

    Dr Yulia A Desheva, Prof. Alexander N Suvorov

  18. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers

    Article • BMC Research Notes, April 2015, Springer Science + Business Media

    Dr Yulia A Desheva

  19. Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models

    Article • The Open Microbiology Journal, January 2015, Bentham Science Publishers

    Dr Yulia A Desheva

  20. Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

    Article • PLoS ONE, February 2014, PLOS

    Dr Yulia A Desheva

  21. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza

    Article • Influenza and Other Respiratory Viruses, November 2008, Wiley

    Dr Yulia A Desheva

  22. 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry

    Article • Virology Journal, January 2008, Springer Science + Business Media

    Dr Yulia A Desheva

  23. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential

    Article • Vaccine, November 2006, Elsevier

    Dr Yulia A Desheva

  24. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses

    Article • Vaccine, November 2006, Elsevier

    Dr Yulia A Desheva

  25. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents

    Article • Vaccine, September 2000, Elsevier

    Dr Yulia A Desheva